UTI-lizer
About:
UTI-lizer develops diagnostic tests for urinary tract infections.
Website: https://www.utilizer.se
Top Investors: Almi Invest, Sting, Propel Capital
Description:
UTI-lizer is a non-optimal treatment and unnecessary use of antibiotics. They detect bacteria in the clinically relevant range, without any complicated lab instruments. They provide biotechnology research. The contact modes are by mail, phone, and physical address.
Total Funding Amount:
7M SEK
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Stockholm, Stockholms Lan, Sweden
Founded Date:
2021-01-01
Founders:
Emre Iseri, Sofia Bertling
Number of Employees:
1-10
Last Funding Date:
2023-05-17
IPO Status:
Private
Industries:
© 2025 bioDAO.ai